Mesothelioma Treatment (s) that beat the odds-

Share Button

Conventional oncology cannot offer much to the Mesothelioma patient. Studies cite longer overall survival through a multimodal  approach to mesothelioma therapy such as surgery, supplementation, etc.

A diagnosis of cancer is difficult. A diagnosis of an “incurable” cancer is beyond difficult. The only good thing about an incurable cancer diagnosis is that it gives the mesothelioma patient a “get out of jail free” card. Meaning, if your oncologist tells you that he or she can’t prescribe mesothelioma treatment to cure your cancer then you are free to look at non-conventional meso therapies.

Image result for image of mesothelioma

You are forced to think outside the box. You want to beat the odds.

It could be that you must undergo an aggressive surgery called extrapleural pneumonectomy (EPP). If this is the case then the pressure is really on you to think through what you can do to improve your odds of managing your EPP.

The study linked and excerpted below talks about identifying those factors that may indicate longer overall survival for extra pleural pneumonectomy survivors. 

Curcumin and bromelain (Wobenzym N) have been shown to improve overall survival in meso patients. While my cancer, multiple myeloma, is very different from mesothelioma, I have been supplementing with Curcumin and bromelain for years and have remained cancer free since ’99. I take Life Extension Super Bio-Curcumin because studies show this formulation is the most “bioavailable” of all Curcumin formulations.

I take Wobenzym N for bromelain because studies have shown the formulation of  Wobenzym N –  (including bromelain) to kill cancer.

Other questions you may ask:

  • Who/where are the best mesothelioma oncologists in the United States?
  • Should I consider radiation therapy too?
  • Are there other non-conventional therapies to increase my overall survival?

For more information about non-conventional therapies to improve your overall survival, scroll down the page, post a question or comment and I will reply ASAP.

thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Cryoablation Successfully Treats Recurrent Mesothelioma

“Radiologists at the UCLA Medical Center are successfully killing tumor cells with extreme cold, also known as cryoablation, in patients with recurrent pleural mesothelioma…”


Extrapleural pneumonectomy (EPP): removal of the affected lung, plus part of the diaphragm, the parietal pleura (lining of the chest) and the pericardium (lining of the heart) on that side.[1] The linings are replaced by Gore-Tex in this radical and painful surgery that is used primarily for treatment of malignant mesothelioma.”

Mesothelioma Patients Live Longer with Multimodal Treatment

“Meaning because conventional oncology has no curative therapies for my cancer I have been forced to think outside-the-box. I think meso patients should think the same way I do…

Prognostic Score of Long-Term Survival After Surgery for Malignant Pleural Mesothelioma: A Multicenter Analysis

“Background– Despite ongoing efforts to improve therapy in malignant pleural mesothelioma, few patients undergoing extrapleural pneumonectomy experience long-term survival (LTS). This study aims to explore predictors of LTS after extrapleural pneumonectomy and to define a prognostic score…

Methods– From January 2000 to December 2010, we retrospectively reviewed clinicopathologic and oncological factors in a multicenter cohort of 468 malignant pleural mesothelioma patients undergoing extrapleural pneumonectomy. LTS was defined as survival longer than 3 years…

Results- Overall, 107 patients (22.9%) survived at least 3 years.

Median overall, cancer-specific, and disease-free survival times were 60, 63  and 49 months respectively. At multivariate analysis,

  • age
  • epithelioid histology,
  • no history of asbestos exposure
  • and the ratio between metastatic and resected lymph nodes less than 22%

were independent predictors of LTS.

Conclusions- Our prognostic model facilitates the prediction of LTS after surgery for malignant pleural mesothelioma and can help to stratify the outcome and, eventually, tailor postoperative treatment.”

Leave a Comment:

Add Your Reply